These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24818704)

  • 1. Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches.
    Villemagne B; Flipo M; Blondiaux N; Crauste C; Malaquin S; Leroux F; Piveteau C; Villeret V; Brodin P; Villoutreix BO; Sperandio O; Soror SH; Wohlkönig A; Wintjens R; Deprez B; Baulard AR; Willand N
    J Med Chem; 2014 Jun; 57(11):4876-88. PubMed ID: 24818704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors.
    Flipo M; Desroses M; Lecat-Guillet N; Villemagne B; Blondiaux N; Leroux F; Piveteau C; Mathys V; Flament MP; Siepmann J; Villeret V; Wohlkönig A; Wintjens R; Soror SH; Christophe T; Jeon HK; Locht C; Brodin P; Déprez B; Baulard AR; Willand N
    J Med Chem; 2012 Jan; 55(1):68-83. PubMed ID: 22098589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-Based Optimized EthR Inhibitors with
    Villemagne B; Machelart A; Tran NC; Flipo M; Moune M; Leroux F; Piveteau C; Wohlkönig A; Wintjens R; Li X; Gref R; Brodin P; Deprez B; Baulard AR; Willand N
    ACS Infect Dis; 2020 Mar; 6(3):366-378. PubMed ID: 32011115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.
    Flipo M; Desroses M; Lecat-Guillet N; Dirié B; Carette X; Leroux F; Piveteau C; Demirkaya F; Lens Z; Rucktooa P; Villeret V; Christophe T; Jeon HK; Locht C; Brodin P; Déprez B; Baulard AR; Willand N
    J Med Chem; 2011 Apr; 54(8):2994-3010. PubMed ID: 21417236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis.
    Flipo M; Willand N; Lecat-Guillet N; Hounsou C; Desroses M; Leroux F; Lens Z; Villeret V; Wohlkönig A; Wintjens R; Christophe T; Kyoung Jeon H; Locht C; Brodin P; Baulard AR; Déprez B
    J Med Chem; 2012 Jul; 55(14):6391-402. PubMed ID: 22738293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligands.
    Crauste C; Willand N; Villemagne B; Flipo M; Willery E; Carette X; Dimala MM; Drucbert AS; Danze PM; Deprez B; Baulard AR
    Anal Biochem; 2014 May; 452():54-66. PubMed ID: 24561027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays.
    Nikiforov PO; Blaszczyk M; Surade S; Boshoff HI; Sajid A; Delorme V; Deboosere N; Brodin P; Baulard AR; Barry CE; Blundell TL; Abell C
    ACS Chem Biol; 2017 May; 12(5):1390-1396. PubMed ID: 28314097
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Sawicki R; Ginalska G
    Future Med Chem; 2019 Aug; 11(16):2193-2203. PubMed ID: 31538522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into mechanisms of induction and ligands recognition in the transcriptional repressor EthR from Mycobacterium tuberculosis.
    Frénois F; Baulard AR; Villeret V
    Tuberculosis (Edinb); 2006 Mar; 86(2):110-4. PubMed ID: 16243584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulator.
    Willand N; Desroses M; Toto P; Dirié B; Lens Z; Villeret V; Rucktooa P; Locht C; Baulard A; Deprez B
    ACS Chem Biol; 2010 Nov; 5(11):1007-13. PubMed ID: 20704273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2.
    Wohlkönig A; Remaut H; Moune M; Tanina A; Meyer F; Desroses M; Steyaert J; Willand N; Baulard AR; Wintjens R
    Biochem Biophys Res Commun; 2017 May; 487(2):403-408. PubMed ID: 28416386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters.
    Nikiforov PO; Surade S; Blaszczyk M; Delorme V; Brodin P; Baulard AR; Blundell TL; Abell C
    Org Biomol Chem; 2016 Feb; 14(7):2318-26. PubMed ID: 26806381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
    Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR
    Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and docking studies of potent ethionamide boosters.
    Tatum NJ; Villemagne B; Willand N; Deprez B; Liebeschuetz JW; Baulard AR; Pohl E
    Acta Crystallogr C; 2013 Nov; 69(Pt 11):1243-50. PubMed ID: 24192167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mycobacterium tuberculosis transcriptional repressor EthR is negatively regulated by Serine/Threonine phosphorylation.
    Leiba J; Carrère-Kremer S; Blondiaux N; Dimala MM; Wohlkönig A; Baulard A; Kremer L; Molle V
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1132-8. PubMed ID: 24667600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis of some new (2-aminothiazol-4-yl)methylester derivatives as possible antimicrobial and antitubercular agents.
    Karuvalam RP; Haridas KR; Nayak SK; Row TN; Rajeesh P; Rishikesan R; Kumari NS
    Eur J Med Chem; 2012 Mar; 49():172-82. PubMed ID: 22280817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosis.
    Prieri M; Frita R; Probst N; Sournia-Saquet A; Bourotte M; Déprez B; Baulard AR; Willand N
    Eur J Med Chem; 2018 Nov; 159():35-46. PubMed ID: 30268015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New active leads for tuberculosis booster drugs by structure-based drug discovery.
    Tatum NJ; Liebeschuetz JW; Cole JC; Frita R; Herledan A; Baulard AR; Willand N; Pohl E
    Org Biomol Chem; 2017 Dec; 15(48):10245-10255. PubMed ID: 29182187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2.
    Prevet H; Moune M; Tanina A; Kemmer C; Herledan A; Frita R; Wohlkönig A; Bourotte M; Villemagne B; Leroux F; Gitzinger M; Baulard AR; Déprez B; Wintjens R; Willand N; Flipo M
    Eur J Med Chem; 2019 Apr; 167():426-438. PubMed ID: 30784877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.